Measurement | Instrument | Nr. of items | Time-points | |||
---|---|---|---|---|---|---|
Baseline (T0-months) | Post treatment (T3 months) | Follow-up T6 months | Follow-up T12* months | |||
Primary outcomes | ||||||
Sleep efficiency (SE) | Actigraph and sleep log | – | X | X | X | X |
Insomnia Severity | ISI | 7 | Assessed in screening | X | X | X |
Secondary outcomes: | ||||||
Sleep parameters: TST, TTB, SOL, WASO, napping | Actigraph and sleep log | X | X | X | X | |
Circadian rhythm parameters: Fragmentation (IV) and intradaily stability (IS) | Actigraph and sleep log | X | X | X | X | |
Health-Related (HR) quality of life | PedsQL - teens 13–18 years - young adult 19–30 years | 23 | X | X | X | X |
Fatigue | CIS | 20 | X | X | X | X |
Depressive and anxiety symptoms | HADS | 14 | X | X | X | X |
Perceived cognitive functioning | Peds-PCF-SF | 10 | X | X | X | X |
Chronic stress | CSQ-CA | 19 | X | X | X | |
General questionnaire | Pain Sleep medication use | 2 | X | X | X | X |
Intervention feedback | Satisfaction questionnaire, adherence | 20 | X*/X** |